These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17540653)

  • 1. Early development of disseminated nocardiosis during immunosuppressive treatment for pemphigus vulgaris.
    Carducci M; Nosotti L; Calcaterra R; Bonifati C; Mussi A; Pelagalli L; Di Emidio L; Laurenzi L; Russo A; Franco G; Toma L; Morrone A
    Eur J Dermatol; 2007; 17(4):346-7. PubMed ID: 17540653
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous and pulmonary nocardiosis in pemphigus vulgaris: a rare complication of immunosuppressive therapy.
    Asilian A; Yoosefi A; Faghihi G
    Int J Dermatol; 2006 Oct; 45(10):1204-6. PubMed ID: 17040442
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive therapy of pemphigus vulgaris complicated by Nocardia pneumonia. Gold as an alternate therapy.
    Murdock DK; Lookingbill DP
    Arch Dermatol; 1990 Jan; 126(1):27-8. PubMed ID: 2105086
    [No Abstract]   [Full Text] [Related]  

  • 4. Pemphigus vulgaris and disseminated coccidioidomycosis.
    Krulig L; Jacobs PH; Loeffel D
    Sabouraudia; 1976 Mar; 14(1):5-9. PubMed ID: 1265574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris.
    Firooz A; Ghandi N; Hallaji Z; Chams-Davatchi C; Valikhani M; Karbakhsh Davari M
    Arch Dermatol; 2008 Sep; 144(9):1143-7. PubMed ID: 18794458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemphigus vulgaris and disseminated nocardiosis.
    Martín FJ; Pérez-Bernal AM; Camacho F
    J Eur Acad Dermatol Venereol; 2000 Sep; 14(5):416-8. PubMed ID: 11305389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strongyloidiasis complicating immunosuppression for pemphigus vulgaris.
    Walker SL; Mann TA
    Br J Dermatol; 2013 Dec; 169(6):1363-4. PubMed ID: 23855642
    [No Abstract]   [Full Text] [Related]  

  • 8. Cerebral nocardiosis.
    Thomas PS; Kiernan MC; Yates DH
    Intern Med J; 2005 Nov; 35(11):685-6. PubMed ID: 16248868
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combined immunosuppressive therapy in patients with pemphigus vulgaris and its side effects].
    Vojácková N; Hejcmanová I; Schmiedbergerová R; Hercogová J
    Cas Lek Cesk; 2005; 144(12):833-5. PubMed ID: 16389757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphomatoid granulomatosis after immunosuppression for pemphigus.
    Jauregui HO
    Arch Dermatol; 1978 Jul; 114(7):1052-5. PubMed ID: 686725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NUDT15 polymorphism and severe azathioprine-induced myelosuppression in a Chinese man with pemphigus vulgaris.
    Yan W; Zhou YH; Wang L; Xiao J; Li W
    Br J Dermatol; 2018 Jan; 178(1):e40-e41. PubMed ID: 28733976
    [No Abstract]   [Full Text] [Related]  

  • 12. Life-threatening course of pemphigus vulgaris complicated by sepsis caused by azathioprine-induced bone marrow suppression, successfully managed with combination therapy.
    Tichy M; Urbanek J; Sternbersky J; Ditrichova D; Hercogova J
    Dermatol Ther; 2014; 27(3):183-6. PubMed ID: 24283408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of disseminated cryptococcosis complicating treatment of pemphigus vulgaris with prednisone and azathioprime].
    Wafa A; Hicham H; Yassir A; Zoubida TM; Mohamed A; Mohamed A; Amine H; Abdelaziz M
    Pan Afr Med J; 2011; 10():35. PubMed ID: 22187617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Nocardiosis in Pemphigus Vulgaris Patients from Tehran, Iran.
    Rahdar HA; Bahador A; Shahraki-Zahedani S; Karami-Zarandi M; Soori T; Jafari S; Feizabadi MM
    Infect Disord Drug Targets; 2021; 21(1):78-83. PubMed ID: 31889503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pemphigus vulgaris and pulmonary nocardiosis.
    Miller RC; Felman YM
    Arch Dermatol; 1967 Nov; 96(5):548-51. PubMed ID: 6054230
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcome of pemphigus vulgaris.
    Kavusi S; Daneshpazhooh M; Farahani F; Abedini R; Lajevardi V; Chams-Davatchi C
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):580-4. PubMed ID: 18194237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment failure with rituximab in a patient with pemphigus vulgaris.
    Weger W; Aberer E
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):387-9. PubMed ID: 18269618
    [No Abstract]   [Full Text] [Related]  

  • 18. Opportunistic infections in patients with pemphigus.
    Leshem YA; Gdalevich M; Ziv M; David M; Hodak E; Mimouni D
    J Am Acad Dermatol; 2014 Aug; 71(2):284-92. PubMed ID: 24815564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laryngeal pemphigus].
    Charpy N; Franck N; Lecanu JB; Pelisse M
    Rev Laryngol Otol Rhinol (Bord); 2006; 127(5):345-8. PubMed ID: 17425010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azathioprine-induced myelosuppression in two pemphigus vulgaris patients with homozygous polymorphism of NUDT15.
    Shih YC; Zou YR; Wang B; Zheng J; Pan M
    J Dermatol; 2019 Feb; 46(2):e59-e61. PubMed ID: 30035323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.